Back to User profile » Dr Silvia Díaz-Cerezo
Papers published by Dr Silvia Díaz-Cerezo:
Higher Compliance with Treatment Administration Instructions for Injectable Dulaglutide versus Oral Semaglutide Reported by People with Type 2 Diabetes in Clinical Practice Settings in Spain: The TRU-Experience Study
Díaz-Cerezo S, Artime E, Redondo-Antón J, Duque N, Spaepen E, Mangas Cruz MÁ, Arnas-Leon C, Olveira G, Rodríguez IR, Julián Alagarda MT, Valdés N, Merchante AÁ, Masmiquel L, Rubio-de Santos M
Patient Preference and Adherence 2025, 19:1231-1244
Published Date: 1 May 2025
The Burden of Suboptimal Insulin Dosing in People with Diabetes in Spain: Barriers and Solutions from the Physician Perspective
Bellido V, Duque N, Newson RS, Artime E, Spaepen E, Rubio de Santos M, Redondo-Antón J, Díaz-Cerezo S, Navarro J
Patient Preference and Adherence 2024, 18:151-164
Published Date: 16 January 2024
Adaptation and Validation of the Spanish Version of Decisional Conflict Scale in People with Migraine in Spain
Guerrero-Peral AL, Porta-Etessam J, Rodríguez-Vico J, Núñez M, Ciudad A, Díaz-Cerezo S, Garí-Peris C, Pérez-Sádaba FJ, Lizán L, Santos-Lasaosa S
Patient Preference and Adherence 2022, 16:3291-3302
Published Date: 15 December 2022
Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain
Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W
ClinicoEconomics and Outcomes Research 2019, 11:395-403
Published Date: 6 June 2019
